Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-17

Clinical Trial Update: HuoXin Pills Intervention on Patients With Coronary Heart Disease After Drug-Coated Balloon Implantation [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating HuoXin Pills for patients with coronary heart disease after drug-coated balloon implantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HuoXin Pills

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Coronary Heart Disease, Medicine, Chinese Traditional | Phase 4 | Status: UNKNOWN